Bone Biologics Corporation
BBLG
$2.16
-$0.04-1.82%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/30/2025
-
GuruFocus
6/30/2025
-
GuruFocus
6/30/2025
-
Business Wire
6/29/2025
-
MarketBeat
6/27/2025
-
MarketBeat
6/27/2025
-
GuruFocus
6/27/2025
-
GuruFocus
6/27/2025
-
GuruFocus
6/27/2025
-
Seeking Alpha - Healthcare
6/27/2025
-
Business Wire
6/27/2025
-
GuruFocus
6/27/2025
-
GuruFocus
6/27/2025
-
GuruFocus
6/27/2025
-
The Fly
6/27/2025
-
Business Wire
6/26/2025
-
GuruFocus
6/26/2025
-
GuruFocus
6/26/2025
-
TipRanks Financial Blog
6/26/2025
-
The Fly
6/26/2025
-
Business Wire
6/24/2025
-
GuruFocus
6/24/2025
-
TipRanks Financial Blog
6/24/2025
-
The Fly
6/10/2025
-
GuruFocus
6/9/2025
-
TipRanks Financial Blog
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 14, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 552 4452
Address
2 Burlington Woods Drive
Burlington, MA 01803
Burlington, MA 01803
Country
Year Founded
Business Description
Sector
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s lead medical device NELL-1/DBM, an...
more